Trials / Conditions / Impaired Renal Function

Impaired Renal Function

17 registered clinical trials studyying Impaired Renal Function.

Status	Trial	Sponsor	Phase
Completed	Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Functi NCT06761131	Ain Shams University	—
Completed	Dapagliflozin Treatment in Type 2 Diabetes NCT04620590	Emerald Clinical Inc.	Phase 4
Completed	Study of Aldafermin (NGM282) in Participants With Impaired Renal Function NCT04179630	NGM Biopharmaceuticals, Inc	Phase 1
Terminated	RI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Renal Impaired Patients and Healthy NCT04252430	MedDay Pharmaceuticals SA	Phase 1
Completed	A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02 NCT03776539	Eloxx Pharmaceuticals, Inc.	Phase 1
Completed	A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function NCT02965040	Astellas Pharma Europe B.V.	Phase 1
Completed	Evaluation of Renal Function Impairment on the Pharmacokinetics of LEE011 NCT02431481	Novartis Pharmaceuticals	Phase 1
Completed	Linagliptin's Effect on CD34+ Stem Cells NCT02467478	George Washington University	Phase 4
Completed	Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6) NCT02087566	Damanhour University	N/A
Completed	Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal Funct NCT01716455	Shire	Phase 1
Unknown	Longterm Follow-up After Remote Ischemic Preconditioning for Prevention of Contrast-induced Nephropathy NCT01760031	University of Cologne	—
Completed	Effects of Obesity Surgery on Renal Function NCT01507350	Imperial College London	—
Completed	Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and I NCT00981045	American Regent, Inc.	Phase 3
Completed	CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment NCT00604357	University of Regensburg	Phase 3
Completed	Pharmacokinetics of Lenalidomide (Revlimid®) in Patients With Multiple Myeloma and Impaired Renal Function NCT00779922	Poitiers University Hospital	Phase 2
Completed	Computer Prescribing System and Impaired Renal Function NCT00784381	Assistance Publique - Hôpitaux de Paris	—
Completed	Platelet Function in Diabetic Patients With and Without Renal Impairment, and the Effects of Lipid Lowering Tr NCT01035320	Karolinska Institutet	Phase 4